<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2150">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05133167</url>
  </required_header>
  <id_info>
    <org_study_id>16112021</org_study_id>
    <nct_id>NCT05133167</nct_id>
  </id_info>
  <brief_title>Balloon Tamponade Vs B-Lynch In Placenta Previa</brief_title>
  <official_title>Comparison of Efficacy of Surgical Interventions (Balloon Tamponade Versus B-lynch Suture) to Prevent Postpartum Hemorrhage in Patients With Placenta Previa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CMH Jhelum</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CMH Jhelum</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients were allocated to group A and B. In group A, balloon tamponade (using Foley catheter&#xD;
      28 Fr) was used intra-operatively to prevent post-partum hemorrhage. In group B, B lynch&#xD;
      suture was used intra-operatively to prevent post-partum hemorrhage.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approval from hospital ethical committee, patients fulfilling the inclusion &amp; exclusion&#xD;
      criteria were recruited after taking informed written consent for surgery. Patients were&#xD;
      allocated to group A and B using computer generated random sample allocation.&#xD;
&#xD;
      In group A, balloon tamponade (using Foley catheter 28 Fr) was used intra-operatively to&#xD;
      prevent post-partum hemorrhage. Post-operative blood loss within first 24 hours was estimated&#xD;
      by measuring the amount of blood collected in Foley balloon tamponade bag, in milliliters.&#xD;
&#xD;
      In group B, B-lynch suture was used intra-operatively to prevent post-partum hemorrhage.&#xD;
      Post-operative blood loss within first 24 hours was estimated by the weight difference of the&#xD;
      pads before and after patient use (1-gram weight difference = 1 ml blood volume lost). Mean&#xD;
      blood loss within first 24 hours post procedure, was compared in both the groups for outcome&#xD;
      measurement.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Actual">October 1, 2021</completion_date>
  <primary_completion_date type="Actual">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean blood loss</measure>
    <time_frame>24 hours post procedure</time_frame>
    <description>Mean blood loss within first 24 hours post procedure, was compared in both the groups for outcome measurement.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Placenta Previa</condition>
  <arm_group>
    <arm_group_label>GROUP A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In group A, balloon tamponade (using Foley catheter 28 Fr) was used intra-operatively to prevent post-partum hemorrhage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GROUP B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In group B, B lynch suture was used intra-operatively to prevent post-partum hemorrhage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Balloon Tamponade or B-Lynch</intervention_name>
    <description>In group A, balloon tamponade (using Foley catheter 28 Fr) was used intra-operatively to prevent post-partum hemorrhage. Post-operative blood loss within first 24 hours was estimated by measuring the amount of blood collected in Foley balloon tamponade bag, in milliliters. In group B, B lynch suture was used intra-operatively to prevent post-partum hemorrhage. Post-operative blood loss within first 24 hours was estimated by the weight difference of the pads before and after patient use (1-gram weight difference = 1 ml blood volume lost). Mean blood loss within first 24 hours post procedure, was compared in both the groups for outcome measurement.</description>
    <arm_group_label>GROUP A</arm_group_label>
    <arm_group_label>GROUP B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Singleton pregnancy&#xD;
&#xD;
          2. Late Third Trimester pregnancy (35+ weeks to 39 weeks)&#xD;
&#xD;
          3. Placenta Previa confirmed by ultrasonography&#xD;
&#xD;
          4. Elective Caesarean Section.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Multiple gestation&#xD;
&#xD;
          2. Placenta accreta Spectrum (accrete/increta/percreta)&#xD;
&#xD;
          3. Bleeding diathesis&#xD;
&#xD;
          4. Other Causes of Post-Partum Hemorrhage i.e. Uterine atony, Genital tract tears,&#xD;
             Retained Products of Conception etc.&#xD;
&#xD;
          5. Serious medical or surgical diseases.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Muhammad Awais Qarni</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesiologist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CMH</name>
      <address>
        <city>Jhelum</city>
        <state>Punjab</state>
        <zip>49600</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 15, 2021</study_first_submitted>
  <study_first_submitted_qc>November 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>CMH Jhelum</investigator_affiliation>
    <investigator_full_name>M. Awais Qarni</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Previa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Will only share primary outcome result.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

